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INTRODUCTION: Smoking is one of the main risk factors for morbidity and mortality. An estimated 59 million (4.4%) disability-
adjusted life years were lost due to smoking throughout the world in 2000. 
OBJECTIVE: To estimate the disease burden attributable to smoking in the State of Rio de Janeiro, Brazil, for the year 2000.
METHODS: Based on estimates of smoking prevalence and relative death risks, the smoking-attributable fraction was calculated 
for each selected cause, by age and gender. The disease burden attributable to smoking was estimated by multiplying the fractions 
by the corresponding disability-adjusted life years. 
RESULTS: In the State of Rio de Janeiro, 7% of all disability-adjusted life years were due to smoking. For individuals 30 or more 
years old, the fraction increased to 10.6% (13.6% in males and 7.5% in females). Chronic obstructive pulmonary disease, ischemic 
heart disease, cerebrovascular disease, and tracheal, bronchial, and lung cancer accounted for 32.2%, 15.7%, 13.2%, and 11.1% of 
the estimated total DALYs, respectively, amounting to 72.2% of the smoking-attributable disease burden. 
DISCUSSION: Limitations related to parameter estimates were not unique to this study, and therefore should not compromise the 
comparability of our results. Outcomes were similar to those obtained in other countries, despite methodological differences. 
CONCLUSION: Smoking is an important risk factor and places a significant disease burden on Rio de Janeiro, Brazil, showing 
a pattern similar to that observed in high income countries.
KEYWORDS: Attributable risk. Epidemiology. Tobacco. Global disease burden.
INTRODUCTION
Tobacco is the single most frequently used and wide-
spread drug in the world and was responsible for approxi-
mately five million recorded deaths in 2000, of which 50% 
were in low/middle income countries.1 It is expected that by 
2020, smoking will account for ten million deaths in high 
income countries and seven million in low/middle income 
countries.2
The harm to human health caused by smoking is widely 
recongnized, and the World Health Organization considers 
tobacco control one of the main public health challenges 
worldwide.3 There is strong evidence that smoking is a causal 
factor for more than 50 different diseases, notably cardio-
vascular and obstructive respiratory diseases and cancer.4,5
According to these studies, 45% of coronary deaths (Acute 
Myocardial Infarction), 85% of deaths from chronic ob-
structive pulmonary disease (COPD), 25% of deaths due to 
cerebrovascular disease (stroke), and 30% of cancer-related 
deaths can be attributed to smoking. According to projections 
by Mathers & Loncar (2006)6, smoking-attributable deaths 
in high-income countries will decrease by 9% between 2002 
and 2030, while they are expected to double from 3.4 to 6.8 
million in low and middle income countries. In 2015, total 
smoking-attributable deaths are expected to surpass HIV/
AIDS-related deaths by 50%. Estimates for 2015 also indi-
cate that smoking will account for approximately 10% of all 
deaths in the world.
Smoking is also directly linked to extraordinary social, 
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economic, and environmental costs. In high income coun-
tries, treatment for diseases related to smoking is estimated 
to represent 6 to 15% of total health expenditures7. As for en-
vironmental damage, in addition to the harm directly linked 
to tobacco smoke itself, the use of pesticides and fertilizers 
in tobacco farming causes pollution, as does the deforesta-
tion required for curing tobacco leaves. 
Smoking is one of the main risk factors in surveys on the 
burden of disease. It is believed that in 2000, smoking was 
responsible for approximately five million deaths (8.8%) and 
59 million (4.1%) Disability-Adjusted Life Years (DALYs) 
in the world.8 This indicator extends the concept of poten-
tial years of life lost due to premature death and includes 
equivalent years of health life lost due to health problems or 
disability. The number of DALYs is calculated as the sum of 
the two quantities: years of life lost due to premature death 
(YLL – years of life lost) and years of life lost due to dis-
ability (YLD – years lived with disability).
In addition, according to the same survey, 66% of 
DALYs due to tracheal, bronchial, and lung cancer, 38% 
due to chronic respiratory disease, and 12% due to vascular 
disease were attributable to smoking. Thus, while in high 
income countries 12% of all DALYs were related to smok-
ing in 2000, in low/middle income countries with low versus 
high mortality rates, the proportions were approximately 4% 
and 2%, respectively.1 However, given the expected increase 
in mortality and sequelae due to smoking in low/middle in-
come countries, added to the fact that treatment and control 
of respiratory abnormalities related to smoking is difficult 
and frequently ineffective,9 this scenario will most likely 
worsen considerably. 
As a major public health issue, the understanding of 
the disease burden attributable to smoking is crucially 
important for the development and deployment of tobacco 
control initiatives, so as to create permanent public poli-
cies that are consistent with health promotion. The disease 
burden attributable to smoking for the State of Rio de Ja-
neiro was estimated based on information from the Global 
Burden of Disease Survey undertaken in Brazil in 1998 
and the National Cancer Institute’s prevalence data on 
current and former smokers for the State capitals of Brazil 
(2002-2003). Rio de Janeiro has the second largest state 
economy in Brazil and a population of 14 million. It also 
has the highest proportion of elderly people (11.5% of the 
population 60 years and older) and is undergoing an ad-
vanced demographic transition. It is thus a very appropriate 
population for this type of survey. 
MATERIAL AND METHODS
Based on a literature review, a list of the main diseases 
associated with smoking was prepared, with the correspond-
ing International Classification of Diseases Tenth Revision 
(ICD 10) codes.10 Therefore, diseases such as malignant 
neoplasm of the lip, oral cavity and pharynx (C00-C14), 
esophagus (C15), stomach (C16), pancreas (C25), larynx 
(C32), trachea, bronchi and lung (C33-C34), cervix uteri 
(C53), bladder (C67), kidneys and other urinary organs (C-
4-C66 and C68), and leukemia (C91-C95) were included in 
the present survey. As for cardiovascular diseases, the list 
included ischemic heart diseases (I20-I25), cerebrovascular 
diseases (I60-I69), atherosclerosis (I70), aortic aneurysm 
and dissection (I71), other heart diseases (I30-I51), and other 
arterial diseases (I72-I78). As for respiratory diseases, the list 
included pneumonia and influenza (J10-J18), bronchitis and 
emphysema (J40-J43), and chronic obstructive pulmonary 
disease (J44). Lastly, perinatal conditions were included 
in the survey, such as short gestation and low birth weight, 
(P07), newborn respiratory distress syndrome (P22), and 
other respiratory conditions originating during the perinatal 
period (P23-P28).
During the Brazilian Burden of Disease Study in 1998, 
estimates were calculated on a national level and for Bra-
zilian Major Regions. Therefore, in order to obtain the 
indicators for the State of Rio de Janeiro for the year 2000, 
the following methodology was applied. First, years of life 
lost due to premature mortality (YLL) according to gender 
and age were calculated based on the Mortality Information 
System. To avoid sudden fluctuations, YLL for 2000 was 
estimated by the yearly mean number of deaths from 1998 
to 2002 by year. Morbidity estimates, measured by years 
lived with disability (YLD) for the year 2000, used the 
same morbidity/mortality ratio (YLL/YLD) that was used 
by the Global Burden of Disease Survey for Brazil11 for 
the Southeast Region for 1998. It was assumed that Rio de 
Janeiro has a morbidity pattern similar to that of the South-
east region as a whole, and that the ratio did not change 
from 1998 to 2000. However, some smoking-attributable 
diseases were not included in Brazil’s Global Burden of 
Disease Survey. Therefore, the YLL/YLD ratio could not 
be calculated for 1998 using the GBD-Brasil-199811 out-
comes. 
Thus, preliminary analyses were performed and cer-
tain decisions were made: (1) cancers of the larynx and 
kidney were estimated according to the YLL/YLD ratio 
for the cancer residual group; (2) cardiovascular diseases 
like atherosclerosis, aortic aneurism, and other arterial 
diseases were calculated according to the cardiovascular 
residual group YLL/YLD ratio; (3) disease causes clas-
sified as “other heart diseases” were estimated according 
to the weighted mean between inflammatory diseases (I-
0-I33, I38, I40-I42) and the cardiovascular residual group, 
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with weights of 2/3 and 1/3, respectively; (4) bronchitis/
emphysema (J40-43) and COPD (J44) were calculated ac-
cording to the YLL/YLD ratio of codes J40-J42 and J44 in 
combination; (5) for pneumonias and influenza (J10-18), 
the ratio observed for acute respiratory diseases was ap-
plied (I.B.01), including codes J10-J18 and J20-J22; (6) 
low birth weight was estimated according to the ratio in 
the group of diseases under codes P05-P07; and (7) for 
newborn respiratory distress syndrome and other conditions 
originating in the perinatal period (P23-P28), the ratio for 
group I.D.02 was applied, including “asphyxia and birth 
trauma” (P03; P10-15, and P20-29).
Two parameters are needed to estimate the population-
attributable fraction: smoking prevalence (risk factor) and 
smoking-attributable relative mortality risk. The data on 
prevalence of current and former smokers by age bracket 
and gender used in this study was obtained from the Na-
tional Self-Reported Disease Survey of the National Cancer 
Institute (INCa, 2002-2003)7, which aims to estimate the 
prevalence of exposure behaviors and risk factors to non-
communicable diseases. These studies included the preva-
lence of exposure behaviors in the Municipality of Rio de 
Janeiro, i.e., 19.8% of men and 15.9% of women. 
The relative mortality risks for the selected diseases in 
this study were based on the “Cancer Prevention Study II” 
(CPS II).5 The CPSII is a nationwide prospective mortality 
study of nearly 1.2 million US adults, aged 30 years or older, 
that began in 1982. These relative risk estimates are shown 
in Figure 1 and are widely used to calculate the smoking-
attributable fraction in different countries.12-20
The disease burden attributable to smoking was calcu-
lated based on the population-attributable fraction (PAF), 
defined as the proportion of a given disease or sequelae at-
tributable to a certain risk factor. In this case, the smoking 
prevalence by gender and age was used, as well as the rela-
tive mortality risk attributable to each smoking-attributable 
disease.
The population-attributable fraction is estimated as:
Where: ip  is the prevalence of the i-th category of the 
risk exposure factor and iRR is its respective risk relative to 
the reference exposure category. 
Multiplying the population attributable fraction by 
DALYs gives us the number of disability-adjusted years of 









Lip, oral cavity and 
pharynx
10.9 3.4 5.1 2.3
Esophagus 6.8 4.5 7.8 2.8
Stomach 2 1.5 1.4 1.3
Pancreas 2.3 1.2 2.3 1.6
Larynx 14.6 6.3 13 5.2
Trachea, lungs, and bronchi 23.3 8.7 12.7 4.5
Cervix uteri _ _ 1.6 1.1
Bladder 3.3 2.1 2.2 1.9
Kidneys, urinary tract 2.7 1.7 1.3 1.1
Acute myeloid leukemia 1.9 1.3 1.1 1.4
Cardiovascular Diseases*
Ischemic heart disease
35-64 years 2.8 1.6 3.1 1.3
q 65 years 1.5 1.2 1.6 1.2
Other heart conditions 1.8 1.2 1.5 1.1
Cerebrovascular disease
35-64 years 3.3 1 4 1.3
q 65 years 1.6 1 1.5 1
Atherosclerosis 2.4 1.3 1.8 1
Aortic aneurism 6.2 31 7.1 2.1
Other arterial diseases 2.1 1 2.2 1.1
Respiratory diseases *
Pneumonia, influenza 1.8 1.4 2.2 1.1
Bronchitis, emphysema 17.1 15.6 12 11.8
Chronic obstructive pulmo-
nary disease
10.6 6.8 13.1 6.8
Perinatal conditions*
Short gestation/low birth 
weight
- - 1.8 -
Respiratory stress syn-
drome
- - 1.3 -
Other conditions arising in 
the perinatal period 
- - 1.4 -
 * q 35 years of age;  Source: USDHHS5.
Figure 1 - Relative risks of the main tobacco-related diseases used in the 
Global Burden of Disease Survey. Rio de Janeiro State, Brazil, 2000
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RESULTS
Twenty-two tobacco-related disease groups (19 adult 
and 3 childhood diseases) resulted in 7% of all DALYs in 
the State of Rio de Janeiro attributable to smoking (5% for 
women and 8.9% for men) (Table 1). However, focusing on 
smoking-attributable DALYs for individuals 30 years and 
older (the group in which smoking-attributable diseases have 
actually become evident), a higher fraction emerges: 10.6% 
overall (13.6% in men and 7.5% in women). 
Among the group of chronic respiratory diseases, 84.4% 
of DALYs are related to bronchitis/emphysema and 76.3% to 
COPD for both sexes combined (Table 2). Considering gen-
der differences in the above-mentioned chronic respiratory 
diseases, smoking-attributable bronchitis/emphysema ac-
counted for 87.8% of DALYs in men and 77.7% in women. 
For COPD, the figures were 77.7% for men and 74% for 
women (Table 2).
For ischemic heart diseases, 32.1% of all DALYs in the 
30-59 age group and 12.3% in the 60-and-over were attrib-
utable to smoking for the two sexes combined. For cerebro-
vascular diseases in men and women, 32.7% and 8.9% of all 
DALYs were smoking-attributable in the 30-59 and q 60 age 
groups, respectively (Table 2).
Cancer of the trachea, bronchi, and lung (81.4%) and 
cancer of the larynx (79.5%) showed the highest smoking-at-
tributable fractions of total DALYs for malignant neoplasms, 
followed by cancer of the lip, oral cavity, and pharynx 
(67.1%) and esophagus (65.6%) (Table 2).
Of the total DALYs due to pneumonia, 19.3% were 
smoking-attributable for both sexes combined (Table 2). 
As for the perinatal period, smoking-attributable low birth 
weight represented 12.5% of all DALYs for male and female 
neonates (Table 2). 
Table 3 shows the absolute and proportional distribution 
of smoking-attributable DALYs, rated according to total 
DALYs: COPD 32.3%, ischemic heart disease 15.7%, and 
cerebrovascular disease 13.2%. Combined, the three diseases 
accounted for 61.1% of all smoking-attributable DALYs in 
the year 2000 in the State of Rio de Janeiro among individu-
als 30 years and older, considering the 22 disease groups 
selected for the study.
DISCUSSION
In the State do Rio de Janeiro, 7.0% of all DALYs are 
smoking-attributable, for all ages. However, analyzing the 
30-year and over age group separately, smoking-attributable 
DALYs increased to 10.6% (13.6% in men and 7.5% in 
women). Men persistently presented a higher attributable 
disease burden than women, due to a higher prevalence of 
smoking in males.21-26
The results are consistent with Mathers et al. (1999)27
for the Global Burden of Disease Survey conducted in 
Australia in 1996, where 9.7% of all DALYs were smoking-
attributable (12.1% in men and 6.8% in women). The State 
of Rio de Janeiro shows patterns similar to those found in 
high income countries.
Cardiovascular diseases were ranked in a relevant posi-
tion among the main diseases associated with DALYs. In 
the current study, of all DALYs from ischemic heart disease 
(IHD), the smoking-attributable faction for the 30-and-over 
group was 20.4%, and for strokes it was 19.4%.
Worldwide, for individuals 30 years and older, 17.0% of 
all DALYs due to ischemic heart disease were attributable to 
smoking28. In low/middle and high income countries, the re-
sults are 15.0% and 23.0%, respectively.28 In Latin America 
and the Caribbean, 14.0% and 15.0% of DALYs caused by 
cerebrovascular disease and ischemic heart disease, respec-
tively, are smoking-attributable in the same age group.28
Based on data from the Global Burden Disease Survey 
2000 (GBD-2000), Ezzati et al. (2003)29 showed that 12.0% 
of all DALYs due to ischemic heart disease and an equal 
proportion for strokes were attributable to smoking. In high 
income countries, 22.0% of such conditions are smoking-
attributable, i.e., the proportions are similar to those in the 
current study.
Even though all age groups were included in the Global 
Table 1 - Disability-adjusted life years (DALYs) and their smoking-attributable fraction, according to gender and estimated 
cause of disease, for individuals q 30 years of age. Rio de Janeiro State, Brazil, 2000
Causes of disease DALYs Attributable fraction (%)
Both Male Female Both Male Female
All causes (all ages) 3,868,987 1,984,049 1,884,939 7.0 8.9 5.0
All causes (q 30 years) 2,536,658 1,287,508 1,249,150 10.6 13.6 7.5
Smoking-attributable causes * (q 30 years) 813,052 461,944 351,108 33.2 38.0 26.8
* Attributable DALYs estimated for selected tobacco-related diseases among individuals 30 years and older: 269,600, 175,656, and 93,944 for both 
sexes, males, and females, respectively. 
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Table 2 - DALYs, smoking-attributable DALYs, and the smoking-attributable fraction, according to gender and smoking-
attributable selected diseases, q 30 years of age. Rio de Janeiro State, Brazil. 2000
Causes of disease DALYs Attributable DALYs Attributable fraction
Both Male Female Both Male Female Both Male Female
Tobacco-related causes* (q 30 years) 813,052 461,944 351,108 269,600 175,656 93,944 33.2 38.0 26.8
Group I.B. Infectious Respiratory Diseases 55,609 29,808 25,801 10,714 6,293 4,421 19.3 21.1 17.1
Pneumonia, Influenza (J10-J18) 55,609 29,808 25,801 10,714 6,293 4,421 19.3 21.1 17.1
Group I.D. Conditions arising in the perinatal 
period
54,957 30,296 24,661 3,960 2,350 1,610 7.2 7.8 6.5
Low birth weight (P07) 9,850 5,038 4,812 1,232 689 543 12.5 13.7 11.3
Respiratory Stress Syndrome (P22) 19,503 11,110 8,393 1,005 623 382 5.2 5.6 4.6
Other conditions originating in the perinatal 
period (P23-P28)
25,604 14,149 11,455 1,723 1,038 685 6.7 7.3 6.0
Group II.A. Malignant neoplasms 131,024 77,700 53,324 63,111 47,121 15,990 48.2 60.6 30.0
Malignant neoplasm of lip, oral cavity and 
pharynx(C00-C14)
14,212 11,358 2,854 9,536 8,216 1,320 67.1 72.3 46.2
Malignant neoplasm of esophagus (C15) 10,484 8,205 2,279 6,879 5,562 1,317 65.6 67.8 57.8
Malignant neoplasm of stomach (C16) 23,073 14,096 8,976 4,435 3,533 901 19.2 25.1 10.0
Malignant neoplasm of pancreas (C25) 9,338 4,746 4,592 2,196 1,129 1,067 23.5 23.8 23.2
Malignant neoplasm of larynx (C32) 6,298 5,514 784 5,006 4,441 565 79.5 80.5 72.1
Malignant neoplasm of trachea, lungs, and 
bronchi (C33-C34)
36,696 24,607 12,089 29,888 21,333 8,554 81.4 86.7 70.8
Malignant neoplasm of cervix uteri (C53) 15,169 15,169 1,520 1,520 10.0 10.0
Malignant neoplasm of bladder (C67) 4,860 3,294 1,566 1,811 1,418 393 37.3 43.0 25.1
Malignant neoplasm of kidneys, urinary tract 
(C64-C66, C68)
3,315 1,980 1,335 764 684 80 23.0 34.5 6.0
Acute myeloid leukemia (C91-C95) 7,581 3,901 3,680 1,077 805 272 14.2 20.6 7.4
Group II.G. Cardiovascular Diseases 436,765 240,636 196,130 87,364 53,593 33,771 20.0 22.3 17.2
Ischemic heart disease (I20-I25) (30-59 yrs.) 84,714 57,447 27,267 27,193 19,658 7,535 32.1 34.2 27.6
Ischemic heart disease (I20-I25) (q 60 yrs.) 122,344 62,385 59,959 15,082 8,306 6,776 12.3 13.3 11.3
Other heart conditions (I29-I51) 35,524 21,477 14,047 4,996 3,771 1,225 14.1 17.6 8.7
Cerebrovascular disease (I60-I69) (30-59 yrs. ) 80,807 43,521 37,286 26,454 13,618 12,836 32.7 31.3 34.4
Cerebrovascular disease (I60-I69) (q 60 yrs.) 102,775 49,362 53,413 9,175 5,242 3,934 8.9 10.6 7.4
Atherosclerosis (I70) 217 143 75 46 38 8 21.2 26.4 11.3
Aortic aneurysm (I71) 6,285 4,196 2,089 3,699 2,584 1,115 58.9 61.6 53.4
Other arterial diseases (I72-I78) 4,100 2,104 1,996 718 376 342 17.5 17.9 17.1
Group II.H. Chronic Respiratory Disease 134,696 83,504 51,193 104,451 66,299 38,152 77.5 79.4 74.5
Bronchitis, emphysema (J40-J43) 20,963 14,077 6,886 17,703 12,355 5,348 84.4 87.8 77.7
Chronic obstructive pulmonary disease (J44) 113,733 69,427 44,306 86,748 53,944 32,804 76.3 77.7 74.0
Burden of Disease Survey in Australia, these conditions only 
become more prevalent in individuals 30 years and older, 
and thus the smoking-attributable burden is more evident in 
this age group and above. In the present study, 15.5% of all 
DALYs to ischemic heart disease and 6.2% of those due to 
strokes were smoking-attributable.27
For malignant neoplasms, 48.2% of all DALYs in the 
30-and-over group were smoking-attributable (60.6% in men 
and 30.0% in women). 
Some studies worldwide have reported that 21.0% of all 
DALYs in the q 30-year group from malignant neoplasms 
are smoking-attributable. In high and low/middle income 
countries respectively, the results are 19.0% and 29.0%28,30.
Although the authors of those studies also worked with 
the 30-and-over group, the lower percentages could be 
explained by the fact that all types of malignant neoplasms 
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were included, while our study used only smoking related 
malignant neoplasms were considered, as described in the 
Methods section.
Meanwhile, chronic respiratory diseases showed the hi-
ghest smoking-attributable fractions: 77.5% overall (79.4% 
in men and 74.5% in women). Within this GBD group (II.H), 
and in both sexes combined, bronchitis and emphysema sho-
wed a smoking-attributable fraction of 84.4%. For COPD, 
the figure was 76.3%. A study in the United States18 from 
1995 to 1999 estimated that 81.7% of mortality from COPD 
in men and 75.1% in women was smoking-attributable.
In the current study, COPD, ischemic heart disease, cere-
brovascular diseases, and cancer of the trachea, bronchi, and 
lung were responsible for 32.2%, 15.7%, 13.2%, and 11.1% 
of all DALYs, respectively, in the 30-and-over group. When 
grouped together, these four disease groups accounted for
72.2% of the smoking-attributable disease burden among 
selected conditions. In the Australian study, lung cancer is 
the main disease, and together with COPD and ischemic 
heart disease it represents 72.0% of the disease burden at-
tributable to smoking and nearly 7.0% of DALYs, for all 
causes of disease.27
For smoking-attributable diseases specific to infants (< 
1 year of age), the I.D. or “perinatal conditions” group pre-
sented an attributable fraction of 7.2% for the entire set of 
causes of disease, and low birth weight showed the highest 
figure: 12.5%. However, this category represents only 0.5% 
of all smoking-attributable DALYs.
The current study presents some limitations that are 
important to discuss. The most important one relates to 
prevalence rates for current exposure, failing to account for 
the latency period between exposure to tobacco and onset of 
symptoms. This was not exclusive to the current study, hav-
ing been identified consistently by other authors.12-15,18,31,32
The use of single prevalence rates, with no distinction for 
rural areas within the State (where higher smoking prevalen-
ce can be expected), should also be considered a limitation, 
resulting in more conservative figures. 
Table 3 - Smoking-attributable DALYs, proportional distribution, and accumulated proportional distribution according to 
diseases in individuals 30 years and older. Rio de Janeiro State, Brazil, 2000
Rank Diseases Smoking-attributable DALYs
number % % accumulated
1 Chronic obstructive pulmonary disease (J44) 86,748 32.2 32.2
2 Ischemic heart disease (I20-I25) (30-59 years) 42,275 15.7 47.9
3 Cerebrovascular disease (I60-I69) (30-59 years) 35,629 13.2 61.1
4 Malignant neoplasm of trachea, lungs, and bronchi (C33-C34) 29,888 11.1 72.2
5 Bronchitis emphysema(J40-J43) 17,703 6.6 78.7
6 Pneumonia, Influenza (J10-J18) 10,714 4.0 82.7
7 Malignant neoplasm of lip, oral cavity and pharynx(C00-C14) 9,536 3.5 86.2
8 Malignant neoplasm of esophagus (C15) 6,879 2.6 88.8
9 Malignant neoplasm of larynx (C32) 5,006 1.9 90.6
10 Other heart conditions (I29-I51) 4,996 1.9 92.5
11 Malignant neoplasm of stomach (C16) 4,435 1.6 94.1
12 Aortic aneurism (I71) 3,699 1.4 95.5
13 Malignant neoplasm of pancreas (C25) 2,196 0.8 96.3
14 Malignant neoplasm of bladder (C67) 1,811 0.7 97.0
15 Other conditions arising in the perinatal period (P23-P28) 1,723 0.6 97.6
16 Malignant neoplasm of cervix uteri (C53) 1,520 0.6 98.2
17 Low birth weight (P07) 1,232 0.5 98.7
18 Acute myeloid leukemia (C91-C95) 1,077 0.4 99.1
19 Respiratory stress syndrome (P22) 1,005 0.4 99.4
20 Malignant neoplasm of kidneys, urinary tract (C64-C66, C68) 764 0.3 99.7
21 Other arterial diseases (I72-I78) 718 0.3 100.0
22 Atherosclerosis (I70) 46 0.0 100.0
Total for all DALYs 269,600 100.0 100.0
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As already indicated by other authors, relative risks 
from the CPS II, used in the current paper, are also ques-
tionable. The information found in CPS II is based on non-
representative population samples, in which married, white, 
higher-income, and more educated individuals were over-
represented, thus limiting the generalization of the results. 
It must be noted that these are national estimates, adjusted 
by age without accounting for other potential confounders 
like alcohol consumption, schooling, hypertension, and 
prevalence of diabetes mellitus.33,34 However, in the absence 
of nationally representative parameters for the Brazilian 
population, these estimates were applied to the data in the 
current paper.
Lastly, the application of mortality risks to DALYs can 
produce misleading results, such that further investigation 
is needed. 
The limitations mentioned here are not exclusive to the 
current study and should not compromise the comparabil-
ity of the estimates. The paper indicates that tobacco is an 
important risk factor and has a great impact, representing 
one in every 7.3 DALYs lost by men and one in every 13.3 
DALYs lost by women in the State of Rio de Janeiro. It is 
therefore of the utmost importance that tobacco prevention 
and control measures be effectively implemented as public 
health policies.
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